On June 26, some exhibitors analyzed the trend of the API industry based on the CPHI China 2025 exhibition. On the one hand, industry integration has accelerated, small and medium-sized pharmaceutical factories have been eliminated, resources have been concentrated in the leaders, and the profit growth rate of 32 leading companies in the API sector in 2024 will be significantly higher than the revenue growth rate; On the other hand, intelligent manufacturing has become the core of cost reduction and efficiency increase, and the gross profit margin of the API sector will rebound to 38% in the first quarter of 2025, and many companies have achieved precise control of the production process and improved R&D efficiency through DCS systems, AI and other technologies.
Release date: 2025.06.26